Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1991-4-15
pubmed:abstractText
Drugs with affinity for phospholipids, such as chlorpromazine, verapamil, tetracaine and imipramine, were found to inhibit accurate transcription from adenovirus 2 major late promoter in a nuclear extract of Ehrlich ascites tumor cells. The transcription activity of the nuclear extract inhibited by chlorpromazine was restored by addition of acidic phospholipids. The nuclear extract was also shown to lose transcription activity when treated with phospholipase A2. Chlorpromazine was found to inhibit transcription at the step of initiation, not elongation. Moreover, it did not affect the activity of purified RNA polymerase II, suggesting the interaction of phospholipids with transcription factors in the nuclear extract. Some transcription factors in the nuclear extract were found to have affinity for cardiolipin, and were precipitated with excess cardiolipin. The transcription factors precipitated with cardiolipin could be solubilized with guanidine hydrochloride, and restored the transcription activity of the cardiolipin-treated nuclear extract.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0006-3002
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
1088
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
191-6
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:2001395-Adenoviruses, Human, pubmed-meshheading:2001395-Animals, pubmed-meshheading:2001395-Carcinoma, Ehrlich Tumor, pubmed-meshheading:2001395-Cell Nucleus, pubmed-meshheading:2001395-Chlorpromazine, pubmed-meshheading:2001395-HeLa Cells, pubmed-meshheading:2001395-Humans, pubmed-meshheading:2001395-Imipramine, pubmed-meshheading:2001395-Kinetics, pubmed-meshheading:2001395-Mice, pubmed-meshheading:2001395-Phospholipases A, pubmed-meshheading:2001395-Phospholipases A2, pubmed-meshheading:2001395-Phospholipids, pubmed-meshheading:2001395-Promoter Regions, Genetic, pubmed-meshheading:2001395-RNA Polymerase II, pubmed-meshheading:2001395-Tetracaine, pubmed-meshheading:2001395-Transcription, Genetic, pubmed-meshheading:2001395-Transcription Factors, pubmed-meshheading:2001395-Verapamil
pubmed:year
1991
pubmed:articleTitle
Inhibitory action of phospholipid-interacting drugs on transcription initiation in a nuclear extract of Ehrlich ascites tumor cells.
pubmed:affiliation
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't